Vance albaugh - curriculum vitae

Vance L. Albaugh, MD, PhD
Phone: (717) 629-1233, Email: [email protected], Fax: (615) 322-0689
EDUCATION

Surgical Residency Training
Vanderbilt University Medical Center; Nashville, Tennessee Medical/Graduate
Pennsylvania State University College of Medicine; Hershey, Pennsylvania USMLE Step 1: 243 (99), July 2007 USMLE Step 2 CK: 255 (99), August 2010 USMLE Step 2 CS: PASS, October 2010 Ph.D., Physiology, Dept. of Cellular & Molecular Physiology, December 2009 Mentor: Christopher J. Lynch, Ph.D. Dissertation: Mechanisms of the Metabolic Side Effects of Atypical Antipsychotic Drugs Undergraduate
Coastal Carolina University; Conway, South Carolina B.S., Biology magna cum laude, Chemistry minor
AWARDS & HONORS

D. Eugene Rannels Award for Outstanding Doctoral Dissertation; Department of Cellular & Molecular Physiology, Penn State College of Medicine. Outstanding Clinical Performance in Surgery; Department of Surgery, Penn State College of Medicine. Young Investigator Research Recognition Award, Endocrinology & Metabolism Section of the American Physiological Society. Howard E. Morgan Award; Department of Cellular & Molecular Physiology. Penn State College of Medicine. Best Overall Presentation, Annual Diabetes and Obesity Research Summit; Penn State Institute for Diabetes and Obesity, Penn State University. American College of Surgeons 96th Annual Clinical Congress, Outstanding Medical Student Poster Award, 2nd Place: Roux-en-Y Gastric-Bypass improves glucose homeostasis and insulin sensitivity in the Zucker Diabetic Fatty Rat. Washington, D.C. Physician-Scientist Trainee Travel Scholarship, Annual Days of Molecular Medicine Symposium, Systems Biology Approaches to Cancer and Metabolic Disease. Karolinska Institutet; Stockholm, Sweden. Joseph E. Johnson Leadership Day Grant; 17th Annual Leadership Day on Capitol Hill, American College of Physicians. College of Medicine Alumni Society Endowed Scholarship, Penn State College of Medicine. Seed Grant Research Project Award. American Medical Association, Foundation. Project: A double blind, placebo-controlled, crossover study examining the acute effects of olanzapine on leptin, oral glucose tolerance and blood lipids in healthy volunteers. Role: Principal Investigator; ClinicalTrials.gov: NCT00741026 Penn State College of Medicine MD/PhD Program Retreat; Abstract Competition, 2nd Place: Mechanisms of Olanzapine-Induced Obesity in Rodents Patrick G. Quinn Award for Outstanding Ph.D. Candidate; Dept. of Cellular & Molecular Physiology, Penn State College of Medicine. Best Overall Poster – Insulin Action & Insulin Resistance Programmatic Area. Penn State Institute for Diabetes & Obesity, Thematic Research Forum. Medical Student Travel Scholarship; Sponsored by the American Psychosomatic Society and the National Institute of Mental Health. Dean’s Travel Award; Penn State University College of Medicine. Annual meeting of the American Psychosomatic Society; Budapest, Hungary. CRC Press LLC, Freshman Chemistry Student Achievement Award; Coastal Carolina University. Academic Scholarship; Coastal Carolina University (1999-2003).
PUBLICATIONS

Albaugh VL, Singareddy R, Mauger D, Lynch CJ. A Double-Blind, Placebo-Controlled, Randomized Crossover
Study of the Acute Metabolic Effects of Olanzapine in Healthy Volunteers. PLoS One 2011 6(8); e22662. (PMID:
21857944)
Culnan DM, Albaugh V, Sun M, Lynch CJ, Lang CH and Cooney RN. Ileal interposition improves glucose
tolerance and insulin sensitivity in the obese Zucker rat. American Journal of Physiology: Gastrointestinal and
Liver Physiology 2010 Jul 15 (PMID: 20634437)

Albaugh VL, Vary T, Ilkayeva O, Wenner BR, Maresca KP, Joyal JL, Breazeale S, Elich T, Lang CH, Lynch CJ.
Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipid, impairing metabolic
flexibility in rodents. Schizophrenia Bulletin 2010 May 21 (PMID: 20494946)

Albaugh VL, Judson JG, She P, Lang CH, Maresca KP, Joyal JL, Lynch CJ. Olanzapine promotes fat
accumulation in male rats by decreasing physical activity, repartitioning energy and increasing lipogenesis while
impairing lipolysis. Molecular Psychiatry 2010 Mar 23 (PMID: 20308992)

Albaugh VL, Henry CR, Bello NT, Hajnal A, Lynch SL, Halle B, Lynch CJ. Hormonal and metabolic effects of
olanzapine and clozapine related to body weight in rodents. Obesity (Silver Spring) 2006 14:1 36-51. (PMID:
16493121)
Pinzon-Guzman C, Albaugh VL, Rzucidlo SE, Berg A, Kulaylat A, and Cilley RE. Pleural Effusion following
Splenic Injury in the Pediatric Trauma Population. (in preparation)
Culnan DM, Albaugh V, Sun M, Lang CH, Lynch CJ, Cooney RN. Roux-en-Y Gastric-Bypass improves glucose
homeostasis and insulin sensitivity in the Zucker Diabetic Fatty Rat. (in preparation)
ABSTRACTS

Panganiban RP, Davis SA, Albaugh VL, Lynch CJ. Obesity/Diabetes-prone Atypical Antipsychotics Elicit a
Rapid Metabolic Toxicity in Mice Treated with CPT1 Inhibitors. Diabetes 2011 60:A442-A521
Albaugh VL, Singareddy RK, Mauger DT, Lynch CJ. In Humans, Olanzapine Acutely Elicits Some But Not All
of the Same Endocrine-Metabolic Changes That Precede Increased Adiposity In Rodent Models. Diabetes 2011
60:A442-A521
Albaugh VL, Singareddy RK, Mauger DT, Ilkayeva O, Wenner BR, Lynch CJ. Olanzapine decreases fatty acids
and impairs glucose tolerance in rodents and humans. FASEB 2011

Albaugh VL, Culnan DM, Sun M, Jetton TL, Lang CH, Lynch CJ, Cooney RN. Roux-en-Y Gastric-Bypass
improves glucose homeostasis and insulin sensitivity in the Zucker Diabetic Fatty Rat. American College of
Surgeons, Clinical Congress; Washington D.C. October 2010.

Albaugh VL, Vary T, Singareddy R, Mauger D, Ilkayeva O, Wenner BR, Lang CH, Lynch CJ. Atypical
Antipsychotics Stimulate Shifts in Peripheral Fuel Selection and Increase Whole-Body Lipid Fuel Oxidation. Mid-
Atlantic Diabetes Symposium, National Institutes of Health, NIDDK. October 2010.
Albaugh VL, Vary T, Ilkayeva O, Wenner BR, Maresca KP, Joyal JL, Breazeale S, Elich T, Lang CH, Lynch CJ.
Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipid, causing metabolic
inflexibility in rodents. 2010 Days of Molecular Medicine, Karolinska Institutet; Stockholm, Sweden.
Albaugh VL and Lynch CJ. Olanzapine increases adiposity in male rats by decreasing physical activity and
partitioning nutrients away from muscle and towards fat. Obesity 2009 17; 11(supp): 179P.

Albaugh VL, Judson JG and Lynch CJ. Using Unexpected Drug Side Effects to Identify Novel Therapeutic
Targets for Diabetes and Obesity. Penn State University Graduate Exhibition, 2009. University Park,
Pennsylvania.
Culnan DM, Albaugh VL, Sun MJ, Lang CH, Lynch CJ and Cooney RN. Ileal Interposition Improves Insulin
Sensitivity in the Zucker Rat. Journal of the American College of Surgeons 2009 209; 3(1): S12-S13.
Albaugh VL and Lynch CJ. Mechanisms of insulin resistance and obesity caused by atypical antipsychotic drugs.
Penn State Institute for Diabetes and Obesity Research Congress, 2008. Hershey, Pennsylvania.
Albaugh VL and Lynch CJ. Olanzapine acutely impairs glucose tolerance and insulin sensitivity in male rats in
the absence of body weight gain and hyperphagia observed in female rats. Penn State Diabetes Research Congress,
2006. Harrisburg, Pennsylvania.
Albaugh VL and Lynch CJ. Role of glucose, insulin and leptin in olanzapine-induced hyperphagia in rats.
Diabetes 2006 Jun 55(supp); A594-95. American Diabetes Association, Washington, D.C.
Albaugh VL and Lynch CJ. Lowered plasma glucose and leptin precede hyperphagia in an animal model of
atypical antipsychotic drug-induced obesity. Penn State Diabetes Research Congress, 2005. State College,
Pennsylvania.
Albaugh VL, Henry CR, Halle BE, Lynch CJ. Topiramate prevents the rapid weight gain and adiposity in a model
of atypical antipsychotic drug-induced obesity. FASEB 2005 19(1); A1130-A1131.

INVITED TALKS & SEMINARS

Albaugh VL, Singareddy RK, Mauger DT, Lynch CJ. Olanzapine Acutely Increases Circulating Triglycerides,
Lowers FFA, Impairs Oral Glucose Tolerance and Decreases HDL Cholesterol: a Randomized Trial of the
Metabolic Effects of Olanzapine in Healthy Volunteers. Penn State Institute for Diabetes & Obesity Research
Summit; State College, Pennsylvania. March 2011.

Albaugh VL, Meng Q, Culnan DM, Pan M, Lynch CJ, Lang CH, Cooney RN. Roux-en Y Gastric Bypass alters
intestinal glucose transport. Journal of the American College of Surgeons 2009 209; 3(1): S12-S13. October 2009.

Albaugh VL and Lynch CJ. Olanzapine rapidly stimulates shifts in peripheral fuel section and increases whole-
body lipid fuel oxidation. Mid-Atlantic Diabetes Symposium, National Institutes of Health, NIDDK. September
2009.

Albaugh VL. Mechanisms of the Metabolic Side Effects of Atypical Antipsychotics. Penn State College of
Medicine, Physiology Graduate Program Seminar Series. August 2009.

Albaugh VL and Lynch CJ. Olanzapine Increases Whole-body Lipid Utilization and Cardiac Work while
Decreasing Cardiac Fuel Availability. The 24th Annual National MD/PhD Student Conference; Keystone,
Colorado. July 2009.

Albaugh VL. Olanzapine Increases Cardiac Work while Decreasing the Availability of its Preferred Fuel, Non-
Esterified Fatty Acids. Research Day 2009, Departments of Medicine and Cellular & Molecular Physiology, Penn
State College of Medicine. June 2009.

Albaugh VL, Judson JG and Lynch CJ. Olanzapine Causes Nutrient Repartitioning Leading to Increased
Adiposity in Male Rats. The Penn State Institute for Diabetes & Obesity Research Congress, 2009. State College,
Pennsylvania. March 2009.

Albaugh VL. Modeling Unexpected Drug Side Effects to Identify Novel Therapeutic Targets for Obesity. Annual
USDA Scholars Undergraduate Research Symposium; Virginia Polytechnic Institute and State University,
Blacksburg, Virginia. August 2008.

Albaugh VL. Mechanisms of Olanzapine-Induced Obesity in Rodents. The Annual Penn State College of
Medicine MD/PhD Program Retreat; State College, Pennsylvania. April 2008.

Albaugh VL. Olanzapine-Induced Obesity and Insulin Resistance in Rats: Early Metabolic Changes Appear to
Explain Sex-dependence. 20th Annual Graduate Student Research Forum, Penn State College of Medicine;
Hershey, Pennsylvania. March 2008.

Albaugh VL. Antipsychotic-Induced Obesity In Rodents. Grand Rounds, Department of Psychiatry, Penn State
College of Medicine; Hershey, Pennsylvania. August 2007.

Albaugh VL. Olanzapine-induced obesity in rats: early metabolic changes appear to explain sex-dependence. The
Penn State Diabetes Center Research Retreat; State College, Pennsylvania. April 2007.

Albaugh VL and Lynch CJ. Olanzapine-induced obesity in rats: early metabolic changes appear to explain sex-
dependence. Obesity 2006 14(supp); 11OR. Annual meeting of NAASO, The Obesity Society; Boston,
Massachusetts.
Albaugh VL, Lynch CJ, Henry C, Halle B, Hajnal A. Acute Lowering of Plasma Glucose and Leptin Appear to
Explain the Hyperphagia and Weight Gain in a Model of Atypical Antipsychotic Drug-Induced Obesity. Obesity
Research 2005 13(supp); A33. Annual meeting of NAASO, The Obesity Society; Vancouver, British Columbia.

TEACHING EXPERIENCE

Instructor, Advanced Trauma & Life Support, American College of Surgeons, 2013-Present Graduate Teaching Assistant for Year 1 Medical Student course, Cellular & Molecular Basis of Medical Practice. Penn State University College of Medicine, 2005-2006. Undergraduate Teaching Assistant for General Chemistry & Organic Chemistry. Coastal Carolina University,
CERTIFICATION & LICENSURE

Certified Instructor, Advanced Trauma & Life Support; American College of Surgeons, 7/2013 Advanced Trauma & Life Support Certification, Exp 7/2016 Advanced Cardiovascular Life Support Certification, Exp 12/2014 Basic Life Support Certification, Exp 4/2015

PROFESSIONAL MEMBERSHIPS

Association for Academic Surgery . 2013 – Present American Society for Metabolic and Bariatric Surgery . 2012 – Present American College of Surgeons . 2009 – Present American Physiological Society . 2004 – 2011 The Obesity Society . 2006 – 2011 American Diabetes Association . 2006 – 2011

PROFESSIONAL ACTIVITIES

Peer Reviewer, Expert Review of Neurotherapeutics (2006); Experimental Biology & Medicine (2007); Psychiatry
Research (2008), American Journal of Physiology: Endocrinology & Metabolism (2008) AMA House of Delegates Representative, American Medical Association – Medical Student Section (2009-2011)
North Central Region Representative (MI, OH, PA), Council of Student Members, American College of
Chairman, LCME Medical Student Committee, LCME Re-Accreditation; Penn State College of Medicine
Junior Mentor, Short-Term Education Program for Underrepresented Persons (STEP-UP); National Institute of
Diabetes, Digestive and Kidney Diseases, Penn State College of Medicine (Summer 2008) Student Senator, Senate Committee on Research, Penn State College of Medicine Caucus; Penn State University
Member, Institutional Review Board. Human Subjects Protection Office; Penn State College of Medicine (2007-
President, Student Assembly; Penn State College of Medicine (2007-2008)
Ad Hoc Member, Circulation Review Committee, George T. Harrell Library; Penn State College of Medicine
Council Member, Pennsylvania Chapter of the American College of Physicians (2007-2011)
Class Officer, Medical Student Class of 2009, Committee for Undergraduate Medical Education (2006-07)

Source: http://www.sages.org/tmp/p18292l2a3j7eorj1nh4mj1f3v3.pdf